Assessing Knowledge and Attitude of Healthcare Professionals on Biosimilars: A National Survey for Pharmacists and Physicians in Taiwan
Despite the first approval of biosimilars’ in 2010, biosimilar products usage has remained low in Taiwan. This cross-sectional survey study assessed healthcare professionals’ (HCPs)—hospital pharmacists, oncologists, and rheumatologists—knowledge, and attitudes toward biosimilars. More precisely, th...
Guardado en:
Autores principales: | Samantha Yun-Kai Poon, Jason C. Hsu, Yu Ko, Shao-Chin Chiang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/24f10e340e724dc19cd37177c1b0e186 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biosimilars: presumption of guilt
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2011) -
Community pharmacists' preparedness for substituting biologics and dispensing biosimilars – Lessons learned from a multinational survey
por: Isabelle Arnet, et al.
Publicado: (2021) -
Biosimilars in the management of neutropenia: focus on filgrastim
por: Caselli D, et al.
Publicado: (2016) -
Gene Therapy Knowledge and Attitude Among Healthcare Professionals: A Cross-Sectional Study
por: Maha M. AlRasheed, et al.
Publicado: (2021) -
Biosimilars and the extrapolation of indications for inflammatory conditions
por: Tesser JRP, et al.
Publicado: (2017)